This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections.

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) shares are gaining after announcing positive European Medicines Agency feedback on its proposed single confirmatory Phase 3 study of investigational ...

Activated caspase-1 cleaves pro-IL-1β, pro-IL-18, and GSDMD to produce IL-1β, IL-18, and GSDMD-N. GSDMD-N inserts into the lipid structure of the cell membrane to form a plasma membrane pore, causing ...

Following every bankruptcy, a company's investors, suppliers, customers, and employees invariably ask themselves: "Could we have seen it coming? Could we have predicted that the company was in big ...

Most people have heard the term upper respiratory infection. It is often used interchangeably when describing a respiratory virus or the common cold. But do you know what a lower respiratory infection ...

Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the bronchi and the lungs. They range from acute infections, such as ...

Oct. 4, 2024 — The University of Cincinnati's Debanjan Bhattacharya is first author of new research published in Cancers that found the drug AM-101 improves the effectiveness and survival rate ...